Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-10

Clinical Trial Update: A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pessary plus progesterone to prevent preterm birth in twin gestations with a short cervix; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Short Cervical Length | Phase 3 | Status: COMPLETED | Results posted: 2026-03-10